Efficacy and Safety of Empagliflozin (BI 10773) Versus Placebo and Sitagliptin Over 24 Weeks in Patients With Type 2 Diabetes
Clinical trial NCT01177813 · COMPLETED
Trial details
- NCT number
- NCT01177813
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2012-03-01
- Enrollment
- 986
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.